CA-102L

N/A

Report date: 2023/12/14 18:18:23

Base Information

Drug NameCA-102L
Drug Alias NameHA-lenalidomideHyaluronic acid-lenalidomide conjugateLen-HA ConjugateCA102LCA-102L
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Molecular Glue
Mechanisms of ActionCD44 antigen inhibitorsCell proliferation inhibitorsImmunomodulators
TargetsCD44 antigen
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHoly Stone Healthcare Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHoly Stone Healthcare Co Ltd
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A